|Year : 2019 | Volume
| Issue : 2 | Page : 112-118
Pharmaceutico-analytical study of Adraka Khanda
Neha S Chavhan, Bharat Rathi
Department of Rasashastra and Bhaishajya Kalpana, Mahatma Gandhi Ayurved College, Hospital & Research Centre, Wardha, Maharashtra, India
|Date of Web Publication||21-Nov-2019|
Dr. Neha S Chavhan
Flat No. 203, Gajanan Shiwani Apartment, Sawangi (M), Wardha, Maharashtra.
Source of Support: None, Conflict of Interest: None
Background: Adraka (Zingiber Officinale) Khanda described in Bhaishajya Ratnavali is a drug of choice in Udarda (Pressure Urticaria), Shittapitta (Cold Urticaria) and Koth (Solar Urticaria) such as autoimmune system. This formulation is having spicy test. Khanda being one of the common dosage from appreciated by all age group for their palatability and easy method of administration and feasibility. Pharmaceutical standardization of this formulation is not established yet, which is first step towards research on the formulation. Hence present work was planned. Material and Method: Three batches of Adraka were prepared by adopting reference of Bhaishajya Ratnavali and the average required for preparation of Adraka Khanda was one day. A constant heat of 90 to 100 °C was maintained throughout the procedure. Result and Conclusion: The analytical study revealed average observed values of pH (6.2), Acid insoluble ash (0.50), Moisture content (3.5), Water extract (23.2) Alcoholic extract (20.8), Water soluble ash (4.3) , Total ash (5.2).
Keywords: Adraka Khanda, Khanda, phytochemical analysis
|How to cite this article:|
Chavhan NS, Rathi B. Pharmaceutico-analytical study of Adraka Khanda. J Indian Sys Medicine 2019;7:112-8
| Introduction|| |
Bhaishajya in accordance to the requirement is flourished by undergoing different modulations. These efforts designed a new branch Bhaishajya Kalpana, an Ayurveda pharmaceutical sciences. The medicinal formulations are prepared by potentiating properties of drugs. It aids a physician to use formulations in various forms and techniques to fight the disease. There are many pharmaceutical methods developed for various medicines preparation to compete with need of all time availability, easy dispensing, and efficacy. In the same sequence, Acharya has mentioned different formulations, such as decoctions, powders, tablets, and Avalehas semi-solid medicated formulations, with similar herbal ingredients but vary in proportion of ingredients, efficacy, dose, and palatability, and so on.
In Ayurveda classics, skin disorders have been mentioned under Rakta and Mamsavaha Srotodushthi Vikaras (diseases of blood and muscle channel),Shittapitta (urticaria) is one of the skin disease these channels. Shittapitta, explained as an independent disease in Ayurveda, can be correlated with urticaria which is common complaints in day-to-day practice. Khanda is a granule preparation and its assimilation starts from the buccal cavity. It has been appreciated by all age groups for their palatability and easy method of administration. It can be compared with the confectionaries. These can be defined as a part of food that provides medical or health benefit along with the prevention and treatment of disease.Haridra (Curcuma longa) Khanda and Narikela (Cocos nucifera) Khanda are some of the examples.
Adraka Khanda is a herbal formulation, which is explained in Bhaishajya Ratnavalli in the context of Udarda Shittapitta Kotha Adhyaya. The ingredients of Adraka Khanda are Adraka, Pippali (Piper longum Linn.), Pippalimula (Piper longum roots), Marich (Piper nigrum Linn.), Sunthi (Zingiber officinale), Chitrakmula (Plumbago zeylanica), Vidang (Embelia ribes), Nagarmotha (Cyperus scariosus), Nagekshar (Mesua ferrea), Twak (Cinnamomum zeylanicum Blume), Ela (Elettaria cardamomum Maton), Tejapatra (Cinnamomum tamala), Kachur (Curcuma zedoaria), Go-ghrita (Butyrum departum), Go-dugdha (milk), and Sharkara (sugar). Adraka, which is considered as a good flavoring agent and part of household spices, has many medicinal properties. It is considered as an important ingredient of all Ayurveda medicines. Since ginger has many medicinal properties it is part of, treatment of many ailments including diarrhea, stomach aches, Chronic obstructive pulmonary disease, and Gastrointestinal tract distribution of nausea. Hence, this study was planned for the preparation and analysis of Adraka Khanda.
| Aims and Objectives|| |
- To prepare Adraka Khanda according to Bhaishajya Ratnavalli
- To study the physicochemical parameters of individual drugs and Adraka Khanda
| Materials and Methods|| |
The raw materials required for the preparation of Adraka Khanda were collected from trusted herbal raw drug provider from the local market of Wardha. Preparation and analytical study of Adraka Khanda was carried out at the Mahatma Gandhi Ayurved College Hospital and Research Centre, Salod (H), Wardha, Maharashtra, India.
| Pharmaceutical Preparation of Adraka Khanda|| |
Raw materials of Adraka Khanda Procedure photo
Drug numbers 2–13 given in [Table 1] and [Figure 1][Figure 2][Figure 3][Figure 4][Figure 5][Figure 6][Figure 7][Figure 8][Figure 9][Figure 10] are finally powdered and sieved through cloth and kept separately. Wet Adraka (rhizome) is collected, cleaned well, external covering is separated with knife, and is made into fine Kalka form. The Kalka is fried with Go-ghrita on Mandagni (low fire) till Ghrita is separated from Kalka. Fried Kalka is boiled with milk to the consistency of soft paste on Mandagni. In another vessel, sugar is taken and mixed with appropriate quantity of water and boiled on Mandagni till it attains Madhyama paka. To this, Adraka paste is added and mixed thoroughly. Fine powders of drug numbers 2–13 are added and mixed thoroughly and made into a homogenous mixture as soon as the vessel is taken out of fire [Figure 11][Figure 12][Figure 13][Figure 14][Figure 15][Figure 16][Figure 17]. On cooling, it is preserved in a wide-mouthed vessel [Figure 18] and [Figure 19]. Texture, odor, and color of the individual drugs and Adraka Khanda were assessed as shown in [Table 3]. Individual raw drugs and Adraka Khanda were analyzed for loss on drying, extractive values, ash values, and pH as per the standard method prescribed in Ayurvedic Pharmacopoeia of India (API) as shown in [Table 4]. Individual raw drugs and Adraka Khanda were analyzed for preliminary phytochemical analysis as prescribed in API and presented in [Table 5]., , , , , , , , , , , , , , , , , , , , , ,
|Table 5: Average result of microbial contamination specification of Adraka Khanda for internal use|
Click here to view
| Observation and Results|| |
After adding Sharkara (sugar) to the decoction, effervescence was observed, which subsided on constant stirring. Gradual thickening of syrup, consistency of Tantumatwa (threadlike) and Darvi pralepa (adhesion of syrup to spoon), was observed in 1h 30min of heating. After 1h 50min of heating, the syrup was found to be in two-thread consistency with Apsumajjan (dipping in water). Bindu paka (settled drop of syrup in water) with Paititastu na Shriyate (not instant dissolution in water) was observed after 2h and 5min. Adraka Khanda was obtained in three batches.
| Discussion|| |
Adraka Khanda generally composes of fresh Kalka (paste) extracted from roots, but in this study, it was not preferred as procuring fresh each time for large-scale production was not feasible. According to Bhaishajya Ratnavalli, it advisable to use Kalka observed after adding sugar to decoction, which needs continuous observation and stirring. As the moisture content reduces in syrup, cohesive force increases and further application of heat imparts kinetic movement to the sugar molecules, and when it is cooled, loss of kinetic movement makes the sugar molecules to coalesce. This explains the reasoning behind thickening and solidifying after cooling. Sugar percentage up to 60%–70% [Table 2] is required for granule preparations, which can be accessed when mixture of sugar and reaches more than two-thread consistency. This stage indicates less moisture content in the Khanda. In previous study time required of Khanda preparation was noted up to 6h 40min. Average time required for preparation of Khanda was 6h 40min after adding to the decoction it took average 1h 30min to attain one-thread consistency and next 20–30min in previous granules study also have same time required for formation of desired consistency required for preparation of Khanda.
The temperature during the whole process was maintained under 100°C for optimum preservation of active constituents in the product. In API, a formulation Puga (Areca catechu) Khanda is mentioned, which has standard value for analytical parameter such has loss on drying 105°C, total ash, acid-insoluble ash, alcohol-soluble extractive, water-soluble extractive, pH, 5, 2.40,1.00,188.8.131.52.5.0 to 5.5% [Table 6]. However, Adraka Khanda is not mentioned in API. Both formulations come under Khanda Kalpana (preparation), therefore standard parameter mentioned for Puga Khanda can be considered to judge the obtained values in the analysis of Adraka Khanda; after comparing these values, it is evident that analysis of Adraka Khanda is in the range of standards mentioned in API of Puga Khanda. Hence, it can be interpreted that analytical finding of this study can be undertaken as standard for further researches. Adraka Khanda on decoction prepared from was cream color hence obtained batches were also having cream color. Loss on drying at 105°C indicates the presence of moisture content. If moisture content is more than the permissible limit then the formulation is more likely to get infected by fungal growth. Moreover, unwanted changes can also occur due to the presence of more moisture. In the prepared batches, moisture content was much less (3%), that is, this formulation may have more stability. Acid-insoluble ash represents the presence of inorganic content, which is not expected in pure herbal formulation. The obtained value of acid-insoluble ash in all batches was negligible. Insignificant difference was observed in alcohol-soluble extractives, which may be due to addition of flavor. The extractive values, namely water soluble and alcohol soluble, indicate the amount of active constituent in a given amount of plant material when extracted with respective solvents, a lower value compared to standard value indicates the presence of exhausted material. Water-soluble extractive value was also nearly same in all the three batches. This value is related with dissolution in gastrointestinal tract and assimilation along with other liquid media. More water solubility is helpful for internal administration of Adraka Khanda with milk as vehicle. The physical parameter such as pH was determined to avoid gastric irritation. All samples showed acidic pH.
|Table 6: Preliminary phytochemical analysis of raw drug and Adraka Khanda|
Click here to view
One important characteristic is tapped bulk density or simply tapped (tap) density, that is, the maximum packing density of a powder (or blend of powders) achieved under the influence of well-defined, externally applied forces. The minimum packed volume thus achieved depends on a number of factors including particle size distribution, true density, particle shape, and cohesiveness due to surface forces including moisture. Therefore, the tap density of a material can be used to predict both its flow properties and its compressibility. Observed densities of samples are within the committee standard. The finer the particle size more will be the solubility and thus more will be the gastrointestinal absorption. The Adraka Khanda of all batches were fine enough to pass through 80–100 mesh size. As all batches were prepared by taking required hygienic care and by using sterilized instruments, the result of microbial content study showed absence of Enterobacteriaceae, total fungus count, Escherichia More Details coli, Salmonella More Details, Staphylococcus aureus, and Pseudomonas aeruginosa [Table 5].
| Conclusion|| |
Khanda form helps in fixing the dose, easy administration, and also increases the shelf life of the formulation. The adopted manufacturing procedure can be accepted as SMP (standard manufacturing procedure) for Adraka Khanda. The present analytical parameters can be used for routine quality control of the formulations.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Rathi B, Rathi R, Rajput DS . Pharmaceutical standardization of Avalgujadi lepguti
. J Indian Syst Med 2016;4:72-6.
Shastri K. Sutrastahan 18. In: Charak Samhita. Vol. I. Varanasi, India: Chaukhambha Sanskrita Sansthan; 2004. p. 454.
Nandennavar V, Deshpande P. Pharmaceutico analytical study of Adraka Avaleha. Ayurpub 2018;3:56.
Baragi PC, Patgiri BJ, Prajapati PK. Neutraceuticals in ayurveda with special reference to Avaleha Kalpana
. Anc Sci Life 2008;28:29-32.
Bulusu S. Bhavapraksha of Bhavamisra. 1st ed. Vol. II. 16/21. Varanasi, India: Chaukhamba Orientalia; 2018, p. 548.
Anonymous. Ayurvedic Formulary of India. Government of India, Ministry of Health and Family Welfare, Department of India System of Medicine & Homoeopathy. AFI Part II Verse No. 406. 1999. p. 50.
Srikantha Murthy RK. Madhyam Khanda. Slokha No. 3, Chapter 8. In: Sharangdhara Samhita. Varanasi, India: Jaikrishnadas Ayurved Series, Chaukhamba Orientalia; Reprint 2012. p. 11.
Seth A. Quality evaluation and standardization of Adraka Khanda
an Ayurvedic formulation Ayurvedic Pharmacy Laboratory, Rajiv Gandhi South Campus, Banaras Hindu University Mirapur, India, J Chem Pharm Res 2015;7:523-9.
Gokarna R, Rajput D, Rathi B, Wanjari A. Pharmaceutical standardization of Shatavari granules J Indian Syst Med 2015;3:54.
Anonymous. The Ayurvedic Pharmacopoeia of India. Vol. Part II. 1st ed. Ministry of Health and Family Welfare, Government of India; 1999. p. 28 (Appendix-2.2.102).
Chamundeeswari D, Kanimozhi P, Vasanthkumar, Reddy CU. Formulation and evaluation of churna
for digestive property. Sri Ramachandra J Med 2007:39.
Available from: http://www.pharmaceuticalonline.com/doc/importance-of-powder-density-in-solid-dosage-0001. [Last accessed on 2015 July 09].
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7], [Figure 8], [Figure 9], [Figure 10], [Figure 11], [Figure 12], [Figure 13], [Figure 14], [Figure 15], [Figure 16], [Figure 17], [Figure 18], [Figure 19]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6]